DESAFIOS DA DOENÇA DE PARKINSON: UMA ANÁLISE ABRANGENTE DO ENVELHECIMENTO POPULACIONAL E SEUS IMPACTOS
DOI:
https://doi.org/10.61164/rmnm.v11i1.3008Keywords:
Doença de Parkinson; Neurodegenerativa; Envelhecimento.Abstract
Abstract
The world is currently experiencing a change in the age range of its population. The number of elderly people has been growing exponentially, linked to this factor, the number of illnesses directly related to age is also high. Parkinson's is one of the diseases that frequently affects the elderly in Brazil and around the world. According to data from the Brazilian Institute of Geography and Statistics, life expectancy in 2017 is 76 years and with projections that by 2040 the elderly population will be approximately 17.41%.
In PD, the main clinical manifestation is parkinsonian syndrome, resulting from impairment of the nigrostriatal dopaminergic pathway. PD is the most common cause of “parkinsonism”. This designation is phenomenological and syndromic, and can appear in different pathologies. Parkinsonism is characterized by: Resting Tremor, A rhythmic tremor that usually begins in one of the hands when at rest.
Parkinsonism or parkinsonian syndrome is one of the most types of movement disorders and presents with 4 basic components: akinesia, weakness, tremor and postural instability. At least two of these components are necessary to characterize the syndrome. In the national literature researched, no articles were found that presented valid results of epidemiological studies of Parkinson's disease. The data obtained was through the Brazilian Government's epidemiological data portals, which record that in Brazil, there are no official estimates, but Brazil is going through a demographic transition with an aging population. This leads to the prevalence of common pathologies in old age. According to IBGE, the number of men and women over 60 years of age increased by 18% in the last five years and, in 2017, there were more than 30 million. PD has an unknown origin, however some studies indicate that it can be caused by a set of factors. Among them, you can mention the result of a combination of genetic predisposition with exposure to environmental toxic factors. Before starting treatment for Parkinson's disease, you need to be sure of the diagnosis. Drug treatment cannot abolish all symptoms, and Physiotherapy is therefore recommended.
Keywords: Parkinson's disease; Neurodegenerative; Aging.
References
Barbosa, E. R., & Sallem, F. A. S. (2005). Doença de Parkinson: Diagnóstico. Revista Neurociências, 13(3), 158–165.
Correia, M. das G. da S., Paixão, A. O. da, Jesus, A. V. F. de, Silva, F. S., Messias, G. M. S., Nunes, T. L. G. M., … Gomes, M. Z. (2013). Doença de Parkinson: uma desordem neurodegenerativa. Caderno De Graduação - Ciências Biológicas E Da Saúde - UNIT - SERGIPE, 1(2), 57–65.
COSTA, Maria do Desterro Leiros da et al. Alterações de neuroimagem no parkinso-nismo: estudo de cinco casos. Arquivos de Neuro-Psiquiatria, São Paulo, v. 61, n. 2-B, p. 381-386, jun. 2003.
Cruz-Ferreira A, Fernandes J, Laranjo L, Bernardo LM, Silva A. A systematic review of the effects of Pilates method of exercise in healthy people. Arch Phys Med Rehab 2011;92(12):2071-81
DAUER, W.; PRZEDBORSKI, S. Parkinson’s disease: Mechanism and Models. neuron, New York, v. 39, n. 6, p. 889-909, 2003.
DE FREITAS, Maria Ludmila M. A influência do método Pilates na instabilidade postural e qualidade de vida do paciente com doença de Parkinson. Fisioterapia Brasil, v. 16, n. 2, p. 155-159, 2015.
Dos Santos, Viviane V., et al. "Fisioterapia na doença de Parkinson:
EDWARDS M, QUINN N, BHATIA K: Parkinson’s disease and other movement disorders. 1st edition. Oxford: Oxford University Press, 2008
Falvo M, Schilling B. Earhart M. Parkinson’s Disease and resisti-ve exercise: Rationale, review and recommendations. Movement Disorders 2007; 23(1):1-11
FOLLMER, Cristian; BEZERRA NETTO, Heleno JC. Fármacos multifuncionais: monoamina oxidase e α-sinucleína como alvos terapêuticos na doença de Parkinson. Química Nova, v. 36, p. 306313, 2013.
JANKOVIC J: Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79(4):368-376
JANKOVIC, J. Parkinson’s disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry, Houston, v. 7, n. 9, p. 368-376, set. 2007.
KANG, U. J; FANG, S. (Org.). Doença de Parkinson. In: LOUIS, E. D.; MAYER, S. A.; ROWLAND, L. P. Tratado de Neurologia. 13.ed. Rio de Janeiro: Guanabara Koogan, 2018. p. 702-720.
KANG, U. J; FANG, S. (Org.). Doença de Parkinson. In: LOUIS, E. D.; MAYER, S. A.; ROWLAND, L. P. Tratado de Neurologia. 13.ed. Rio de Janeiro: Guanabara Koogan, 2018. p. 702-720.
KATZ, Sidney et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA: The Journal of The American Medical Association, Chicago, v. 185, n. 12, p. 914-919, Sept. 1963
LAU, L.M.L; BRETELER, M.M.B. Epidemiology of Parkinson’s disease. The Lancet Neurology, Londres, v. 5, n. 6, p. 525-535, jun. 2006.
LEES AJ, HARDY J, REVESz T: Parkinson’s Disease. Lancet 2009;373(9680):2055-2066
MATA, Fabiana Araújo Figueiredo da; BARROS, Alcidezio Luiz Sales; LIMA,
Cláudia Fonseca. Avaliação do risco de quedas em pacientes com Doença de Parkinson. Revista Neurociências, São Paulo, v. 16, n. 1, p. 20-24, 2008.
MELO, L.M; BARBOSA, E; CARAMELLI, P. Declínio Cognitivo e Demência Associados à Doença de Parkinson: Características Clínicas e Tratamento. Revista de Psiquiatria Clínica, São Paulo, v. 34, n. 4, p. 176-183, 2007.
Miami: Pilates Method Alliance;1945.
Muscolino JE, Cipriani S. Pilates and the “powerhouse”- I. J Bodyw Mov Ther 2004 8:15-24.
Pilates JH, Miller WJ. Pilates’return to life through contrology.
PINHEIRO, J. E. S.; BARBOSA, M. T. Doença de Parkinson e Outros Distúrbios do Movimento em Idosos. In: FREITAS, E. V. D.; PY, L. Tratado de Geriatria e Gerontologia. 4.ed. Rio de Janeiro: Guanabara Koogan, 2018. p. 360-370.
SCHAPIRA AH, TOLOSA E: Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat Rev Neurol 2010;6(6):309-317.
Segal NA, Hein J, Basford J. The effects of Pilates training on flexibility and body composition: na observational study. Arch Phys Med Rehabil 2004;85(12):1977-81.
Silva, A. B. G., Pestana, B. C., Hirahata, F. A. A., Horta, F. B. de S., & Oliveira, E. S. B. E. (2021). Doença de Parkinson: revisão de literatura / Parkinson’s Disease: literature review. Brazilian Journal of Development, 7(5), 47677–47698.
Silva, A. B. G., Pestana, B. C., Hirahata, F. A. A., Horta, F. B. de S., & Oliveira, E. S. B. E. (2021). Doença de Parkinson: revisão de literatura / Parkinson’s Disease: literature review. Brazilian Journal of Development, 7(5), 47677–47698.
SILVA, Melany Natuane de Carvalho. Medicamentos utilizados no controle da Doença de Parkinson. 2018.
Souza, C. F. M., Almeida, H. C. P., Sousa, J. B., Costa, P. H., Silveira, Y. S. S., & Bezerra, J. C. L. (2011). A Doença de Parkinson e o Processo de Envelhecimento Motor: Uma Revisão de Literatura. Revista Neurociências, 19(4), 718–723.
uma breve revisão." Rev. bras neurol 46.2 (2010): 17-25.
Vara, A. C., Medeiros, R., & Striebel, V. L. W. (2012). O Tratamento Fisioterapêutico na Doença de Parkinson. Revista Neurociências, 20(2), 266–272.
YSNES, O. B.; STORSTEIN, A. Epidemiology of Parkinson’s Disease. Journal of Neural Transmission, v. 128, [s.n.], p. 901-905, 2017
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
